Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2013 (2013), Article ID 159850, 11 pages
http://dx.doi.org/10.1155/2013/159850
Review Article

A Systematic Review of Depression and Anxiety in Patients with Atrial Fibrillation: The Mind-Heart Link

1Mercy Street Vincent's Medical Center, 2213 Cherry St., Toledo, OH 43608, USA
2Electrophysiology and Cardiac Arrhythmias, Dante Pazzanese Institute of Cardiology, 04012-909 SP, Brazil

Received 30 January 2013; Revised 28 March 2013; Accepted 28 March 2013

Academic Editor: Janusz K. Rybakowski

Copyright © 2013 Dimpi Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Coromilas, “Obesity and atrial fibrillation: is one epidemic feeding the other?” Journal of the American Medical Association, vol. 292, no. 20, pp. 2519–2520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. V. Naccarelli, H. Varker, J. Lin, and K. L. Schulman, “Increasing prevalence of atrial fibrillation and flutter in the United States,” The American Journal of Cardiology, vol. 104, no. 11, pp. 1534–1539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Benjamin, D. Levy, S. M. Vaziri, R. B. D'Agostino, A. J. Belanger, and P. A. Wolf, “Independent risk factors for atrial fibrillation in a population based cohort. The framingham heart study,” Journal of the American Medical Association, vol. 271, no. 11, pp. 840–844, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Fuster, L. E. Rydén, D. S. Cannom et al., “ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: executive summary,” European Heart Journal, vol. 27, no. 16, pp. 1979–2030, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Thrall, D. Lane, D. Carroll, and G. Y. H. Lip, “Quality of life in patients with atrial fibrillation: a systemic review,” The American Journal of Medicine, vol. 119, no. 5, pp. 448.e1–448.e19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Hajduk, M. Korzonek, K. Przybycien, S. Ertmanski, and J. Stolarek, “Measurement of anxiety with C.D. Spielberger's test in patients with cardiac arrhythmias,” Annales Academiae Medicae Stetinensis, vol. 55, no. 1, pp. 48–51, 2009. View at Google Scholar
  7. R. Garg, J. Punj, P. Gupta, V. Darlong, and R. Pandey, “Perioperative atrial fibrillation in five patients—role of anxiety,” Journal of Anaesthesiology Clinical Pharmacology, vol. 27, no. 1, pp. 135–137, 2011. View at Google Scholar · View at Scopus
  8. L. Pozeuelo, “Fine tuning a heart-brain connection: anxiety in atrial fibrillation,” Circulation, vol. 5, no. 3, pp. 307–308, 2012. View at Google Scholar
  9. P. J. McCabe, “Psychological distress in patients diagnosed with atrial fibrillation: the state of the science,” Journal of Cardiovascular Nursing, vol. 25, no. 1, pp. 40–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Hansson, B. Madsen-Härdig, and S. B. Olsson, “Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance,” BMC Cardiovascular Disorders, vol. 4, article 13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. “Statins becoming ever more versatile. Now also for prevention of atrial fibrillation and depression,” MMW Fortschritte der Medizin, vol. 145, no. 16, p. 10, 2003.
  12. A. Hansson and B. Olsson, “Paroxysmal fibrillation as a clinical problem. More studies on the anxiety-inducing disorder are needed,” Lakartidningen, vol. 91, no. 47, pp. 4372–4379, 1994. View at Google Scholar · View at Scopus
  13. R. Dabrowski, E. Smolis-Bak, I. Kowalik, B. Kazimierska, M. Wójcicka, and H. Szwed, “Quality of life and depression in patients with different patterns of atrial fibrillation,” Kardiologia Polska, vol. 68, no. 10, pp. 1133–1139, 2010. View at Google Scholar · View at Scopus
  14. N. Frasure-Smith, F. Lespérance, M. Habra et al., “Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure,” Circulation, vol. 120, no. 2, pp. 134–140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kang, “Effect of uncertainty on depression in patients with newly diagnosed atrial fibrillation,” Progress in Cardiovascular Nursing, vol. 21, no. 2, pp. 83–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Rommel, R. Simpson, J. P. Mounsey et al., “Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation,” The American Journal of Cardiology, vol. 111, no. 2, pp. 208–212, 2013. View at Publisher · View at Google Scholar
  17. S. I. Suzuki and H. Kasanuki, “The influences of psychosocial aspects and anxiety symptoms on quality of life of patients with arrhythmia: investigation in paroxysmal atrial fibrillation,” International Journal of Behavioral Medicine, vol. 11, no. 2, pp. 104–109, 2004. View at Google Scholar · View at Scopus
  18. E. D. Eaker, L. M. Sullivan, M. Kelly-Hayes, R. B. D'Agostino, and E. J. Benjamin, “Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the framingham offspring study,” Psychosomatic Medicine, vol. 67, no. 5, pp. 692–696, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Thrall, G. Y. H. Lip, D. Carroll, and D. Lane, “Depression, anxiety, and quality of life in patients with atrial fibrillation,” Chest, vol. 132, no. 4, pp. 1259–1264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Ong, J. Irvine, R. Nolan et al., “Gender differences and quality of life in atrial fibrillation: the mediating role of depression,” Journal of Psychosomatic Research, vol. 61, no. 6, pp. 769–774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Perret-Guillaume, S. Briancon, D. Wahl, F. Guillemin, and F. Empereur, “Quality of Life in elderly inpatients with atrial fibrillation as compared with controlled subjects,” Journal of Nutrition, Health and Aging, vol. 14, no. 2, pp. 161–166, 2010. View at Google Scholar · View at Scopus
  22. I. Ariansen, T. Dammen, M. Abdelnoor, A. Tveit, and K. Gjesdal, “Mental health and sleep in permanent atrial fibrillation patients from the general population,” Clinical Cardiology, vol. 34, no. 5, pp. 327–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Trovato, P. Pace, E. Cangemi, G. F. Martines, F. M. Trovato, and D. Catalano, “Gender, lifestyles, illness perception and stress in stable atrial fibrillation,” Clinica Terapeutica, vol. 163, no. 4, pp. 281–286, 2012. View at Google Scholar
  24. P. J. McCabe, S. A. Barnason, and J. Houfek, “Illness beliefs in patients with recurrent symptomatic atrial fibrillation,” Pacing and Clinical Electrophysiology, vol. 34, no. 7, pp. 810–820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Ong, R. Cribbie, L. Harris et al., “Psychological correlates of quality of life in atrial fibrillation,” Quality of Life Research, vol. 15, no. 8, pp. 1323–1333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Whang, K. W. Davidson, D. Conen, U. B. Tedrow, B. M. Everett, and C. M. Albert, “Global psychological distress and risk of atrial fibrillation among women: the women's health study,” Journal of the American Heart Association, vol. 1, no. 3, Article ID e001107, 2012. View at Publisher · View at Google Scholar
  27. D. A. Lane, C. M. Langman, G. Y. H. Lip, and A. Nouwen, “Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation,” Journal of Psychosomatic Research, vol. 66, no. 3, pp. 203–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. K. Gehi, S. Sears, N. Goli et al., “Psychopathology and symptoms of atrial fibrillation: implications for therapy,” Journal of Cardiovascular Electrophysiology, vol. 23, no. 5, pp. 473–478, 2012. View at Publisher · View at Google Scholar
  29. Y. J. Son and E. K. Song, “The impact of type D personality and high-sensitivity C-reactive protein on health-related quality of life in patients with atrial fibrillation,” European Journal of Cardiovascular Nursing, vol. 11, no. 3, pp. 304–312, 2012. View at Google Scholar
  30. P. J. Tully, J. S. Bennetts, R. A. Baker, A. D. McGavigan, D. A. Turnbull, and H. R. Winefield, “Anxiety, depression, and stress as risk factors for atrial fibrillation after cardiac surgery,” Heart and Lung, vol. 40, no. 1, pp. 4–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Frasure-Smith, F. Lespérance, M. Talajic et al., “Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the atrial fibrillation and congestive heart failure trial,” Circulation, vol. 5, no. 3, pp. 322–330, 2012. View at Publisher · View at Google Scholar
  32. H. W. Lange and C. Herrmann-Lingen, “Depressive symptoms predict recurrence of atrial fibrillation after cardioversion,” Journal of Psychosomatic Research, vol. 63, no. 5, pp. 509–513, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Fichtner, I. Deisenhofer, S. Kindsmüller et al., “Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation,” Journal of Cardio Electrophysiol, vol. 3, no. 2, pp. 121–127, 2012. View at Google Scholar
  34. A. Wokhlu, K. H. Monahan, D. O. Hodge et al., “Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect,” Journal of the American College of Cardiology, vol. 55, no. 21, pp. 2308–2316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C. H. Sang, K. Chen, X. F. Pang et al., “Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation,” Clinical Cardiology, vol. 36, no. 1, pp. 40–45, 2012. View at Google Scholar
  36. S. Mohanty, P. Mohanty, L. Di Biase et al., “Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation,” Heart Rhythm, vol. 8, no. 12, pp. 1847–1852, 2011. View at Publisher · View at Google Scholar
  37. S. B. Yu, W. Hu, Q. Y. Zhao et al., “Effect of anxiety and depression on the recurrence of persistent atrial fibrillation after circumferential pulmonary vein ablation,” Chinese Medical Journal, vol. 125, no. 24, pp. 4368–4372, 2012. View at Google Scholar
  38. D. Lakkireddy, D. Atkins, J. Pillarisetti et al., “Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA my heart study,” Journal of the American College of Cardiology, vol. 61, no. 11, pp. 1177–1182, 2013. View at Publisher · View at Google Scholar
  39. B. Rudisch and C. B. Nemeroff, “Epidemiology of comorbid coronary artery disease and depression,” Biological Psychiatry, vol. 54, no. 3, pp. 227–240, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. H. G. Koenig, “Depression in hospitalized older patients with congestive heart failure,” General Hospital Psychiatry, vol. 20, no. 1, pp. 29–43, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Barth, M. Schumacher, and C. Herrmann-Lingen, “Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis,” Psychosomatic Medicine, vol. 66, no. 6, pp. 802–813, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. R. J. Aviles, D. O. Martin, C. Apperson-Hansen et al., “Inflammation as a risk factor for atrial fibrillation,” Circulation, vol. 108, no. 24, pp. 3006–3010, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Pasic, W. C. Levy, and M. D. Sullivan, “Cytokines in depression and heart failure,” Psychosomatic Medicine, vol. 65, no. 2, pp. 181–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. M. K. Chung, D. O. Martin, D. Sprecher et al., “C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation,” Circulation, vol. 104, no. 24, pp. 2886–2891, 2001. View at Google Scholar · View at Scopus
  45. J. Dernellis and M. Panaretou, “C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation,” Acta Cardiologica, vol. 56, no. 6, pp. 375–380, 2001. View at Google Scholar · View at Scopus
  46. J. F. Malouf, R. Kanagala, F. O. Al Atawi et al., “High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion,” Journal of the American College of Cardiology, vol. 46, no. 7, pp. 1284–1287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. R. M. Carney, K. E. Freedland, and R. C. Veith, “Depression, the autonomic nervous system, and coronary heart disease,” Psychosomatic Medicine, vol. 67, supplement 1, pp. S29–S33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Murck, K. Held, M. Ziegenbein, H. Künzel, K. Koch, and A. Steiger, “The renin-angiotensin-aldosterone system in patients with depression compared to controls—a sleep endocrine study,” BMC Psychiatry, vol. 3, article 15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Takahashi, O. Kume, O. Wakisaka et al., “Novel strategy to prevent atrial fibrosis and fibrillation,” Circulation Journal, vol. 76, no. 10, pp. 2318–2326, 2012. View at Publisher · View at Google Scholar
  50. V. E. Hagens, K. M. Vermeulen, E. M. Tenvergert et al., “Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation—results from the rate Control versus electrical cardioversion (RACE) study,” European Heart Journal, vol. 25, no. 17, pp. 1542–1549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. G. C. Grönefeld, J. Lilienthal, K. H. Kuck, and S. H. Hohnloser, “Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: results from a prospective randomized study,” European Heart Journal, vol. 24, no. 15, pp. 1430–1436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Berry, “Electrical cardioversion for atrial fibrillation: outcomes in “real life” clinical practice,” International Journal of Cardiology, vol. 81, no. 1, pp. 29–35, 2001. View at Publisher · View at Google Scholar
  53. T. Shirayama, T. Sakamoto, T. Sakatani, H. Mani, T. Yamamoto, and H. Matsubara, “Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation,” The American Journal of Cardiology, vol. 97, no. 12, pp. 1749–1751, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. D. D. Buff, R. Brenner, S. S. Kirtane, and R. Gilboa, “Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease,” Journal of Clinical Psychiatry, vol. 52, no. 4, pp. 174–176, 1991. View at Google Scholar · View at Scopus
  55. S. A. Spier and M. A. Frontera, “Unexpected deaths in depressed medical inpatients treated with fluoxetine,” Journal of Clinical Psychiatry, vol. 52, no. 9, pp. 377–382, 1991. View at Google Scholar · View at Scopus
  56. A. Fayssoil, J. Issi, M. Guerbaa, J. C. Raynaud, and V. Heroguelle, “Torsade de pointes induced by citalopram and amiodarone,” Annales de Cardiologie et d'Angeiologie, vol. 60, no. 3, pp. 165–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. V. M. Castro, C. C. Clements, S. N. Murphy et al., “QT interval and antidepressant use: a cross sectional study of electronic health records,” BMJ, vol. 29, p. f288, 2013. View at Publisher · View at Google Scholar
  58. D. M. Roden, “Drug-Induced Prolongation of the QT Interval,” The New England Journal of Medicine, vol. 350, no. 10, pp. 1013–1022, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. K. A. Cochran, L. H. Cavalarri, N. L. Shapiro, and J. R. Bishop, “Bleeding incidence with concomitant use of antidepressants and warfarin,” Therapeutic Drug Monitoring, vol. 33, no. 4, pp. 433–438, 2011. View at Publisher · View at Google Scholar
  60. S. O. Dalton, C. Johansen, L. Mellemkjaer et al., “Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding a population-based cohort study,” Archives of Internal Medicine, vol. 163, no. 1, pp. 59–64, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. W. E. E. Meijer, E. R. Heerdink, W. A. Nolen, R. M. C. Herings, H. G. M. Leufkens, and A. C. G. Egberts, “Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants,” Archives of Internal Medicine, vol. 164, no. 21, pp. 2367–2370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. Pradaxa Official FDA information, side effects and uses. Drugs.com. Retrieved, 2013.